We are live on
!
Find out more
DGI
Discovery Group I Portfolio holdings
AUM
$262M
1-Year Est. Return
29.24%
This Fund
S&P 500
This Quarter
Est. Return
+7.36%
1 Year Est. Return
+29.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$244M
AUM Growth
–
Cap. Flow
+$245M
Cap. Flow
% of AUM
100.27%
Top 10 Holdings %
Top 10 Hldgs %
83.67%
Holding
18
New
18
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
FMI
Foundation Medicine, Inc.
FMI
|
+$35.4M |
| 2 |
TUBE
TubeMogul, Inc.
TUBE
|
+$31.3M |
| 3 |
HIVE
Aerohive Networks
HIVE
|
+$29.9M |
| 4 |
Agilysys
AGYS
|
+$24.6M |
| 5 |
ASNA
Ascena Retail Group, Inc.
ASNA
|
+$18.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 57.58% |
| 2 | Healthcare | 34.32% |
| 3 | Consumer Discretionary | 0.27% |
Similar funds
FC
GIIO
UBWV
SC
EM
SIMC
BSWMG
PCMI
Discovery Group I's Q3 2016 Portfolio in Review
Q3 2016 is the first quarter with a 13F filing on record for Discovery Group I, which disclosed 18 positions worth $244M. Its ten largest holdings account for 84% of the portfolio.
Its largest position is Foundation Medicine, Inc.: 1,560,614 shares worth $36.4M.
By sector, the portfolio is most concentrated in Technology at 58% of assets, followed by Healthcare and Consumer Discretionary.
- Discovery Group I's largest Q3 2016 buy was Foundation Medicine, Inc.: 1,560,614 shares worth $36.4M.
- Discovery Group I's ten largest holdings make up 84% of its $244M portfolio in Q3 2016.
- Discovery Group I disclosed 18 positions in Q3 2016, its first 13F filing on record.
Based on Discovery Group I's 13F filing for Q3 2016, filed 14 Nov 2016.